NEW YORK Results of an observational study indicate that patients taking Pfizer’s Lipitor (atorvastatin calcium) had a 13 percent reduction in the relative risk of heart-related emergencies ...

The Food and Drug Administration reassured consumers today that the chances for harm from ingesting generic Lipitor that ... Answers to your questions about Ranbaxy's recalled atorvastatin calcium.

Parsippany, N.J. (December 27, 2001) -- WelChol® (colesevelam HCl) and Lipitor® (atorvastatin calcium), taken in combination, can lower LDL cholesterol levels by 48% in patients with moderately ...

The U.S. Food and Drug Administration said it granted Ranbaxy Laboratories Ltd. approval to sell a generic version of Pfizer Inc.'s Lipitor, called atorvastatin calcium.

Consumers and insurers paid more for Lipitor because it kept competing ... and Nov. 29, 2011, or you purchased the generic atorvastatin calcium these locations between Nov. 30, 2011, and Dec ...

Pfizer Inc. (NYSE: PFE) announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high ...

NEW YORK--(BUSINESS WIRE)--The early addition of Lipitor ® (atorvastatin calcium) Tablets to effective blood pressure lowering treatment maintained a significant 36 percent reduction in the ...

Merck and Schering-Plough said Monday that new analysis of a previously released study of its jointly marketed Vytorin (ezetimibe/simvastatin) showed it was better at lowering bad cholesterol levels ...

Canada has approved an expanded indication for atorvastatin calcium tablets (Lipitor), France has approved ropinirole HCl prolonged release tablets (Requip LP), and Japan has approved bevacizumab ...

Ranbaxy recalls generic lipitor Drug manufacturer recalls 41 lots of atorvastatin calcium tablets due to potential contamination with small glass particles. Drug manufacturer Ranbaxy has recalled ...